Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth
30. Dezember 2024 08:00 ET
|
Biora Therapeutics, Inc.
Sale process will help enable next stage of product development Secures up to $10.25 million in new financing to support ongoing business operations SAN DIEGO, Dec. 30, 2024 (GLOBE NEWSWIRE) --...
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
14. November 2024 08:00 ET
|
Biora Therapeutics, Inc.
Testing in advanced animal model planned in Q4 for smaller, 00-size BioJet device with largest capacity of any ingestible injectable Company granted extension until December 9 to regain compliance...
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update
07. November 2024 16:30 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced it will report financial results and...
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
29. Oktober 2024 08:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that it has entered into definitive...
Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting
28. Oktober 2024 08:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today is sharing progress on its development of the...
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting
14. Oktober 2024 08:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that Adi Mohanty, CEO of Biora...
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium
07. Oktober 2024 08:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that company leadership will present at...
Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024
30. September 2024 08:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced an upcoming poster presentation at the...
Biora Therapeutics Achieves ISO 13485 Certification
09. September 2024 08:00 ET
|
Biora Therapeutics, Inc.
ISO certification underscores the company’s commitment to quality and excellence
Biora Therapeutics Announces Positive Nasdaq Listing Decision
28. August 2024 08:00 ET
|
Biora Therapeutics, Inc.
SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that the company has been granted an...